Long term survival in a patient with variant Creutzfeldt-Jakob disease treated with intraventricular pentosan polysulphate.
about
Prion diseases: immunotargets and therapyPentosan Polysulfate: Oral Versus Subcutaneous Injection in Mucopolysaccharidosis Type I DogsHeparin binding confers prion stability and impairs its aggregation.Glycosaminoglycan sulphation affects the seeded misfolding of a mutant prion proteinPostmortem findings in a case of variant Creutzfeldt-Jakob disease treated with intraventricular pentosan polysulfate.Diphenylpyrazole-derived compounds increase survival time of mice after prion infection.Variant CJD. 18 years of research and surveillance.Rapidly progressive dementias and the treatment of human prion diseases.The variant Creutzfeldt-Jakob Disease: Risk, uncertainty or safety in the use of blood and blood derivatives?Therapeutic approaches for prion disorders.Toxic effects of intracerebral PrP antibody administration during the course of BSE infection in mice.Therapies for human prion diseasesInsights from Therapeutic Studies for PrP Prion Disease.Sulfated glycosaminoglycans in protein aggregation diseases.Orally administered amyloidophilic compound is effective in prolonging the incubation periods of animals cerebrally infected with prion diseases in a prion strain-dependent manner.
P2860
Q26741258-9CC471AA-D934-44BB-BA56-705067E04661Q28551264-0DF59D77-F984-4B1A-8DA9-45DFF66559E1Q33613234-CFA52F6B-726B-483F-AF6D-7623139F2F6EQ33680310-D1C0F52D-C893-46E1-A893-39F962BA941EQ33956775-4B7AA48C-59A3-479F-B530-4ABBE7D99319Q33957528-1DFEAB05-3385-492A-A063-394D489D2842Q34453109-9EBE1CDD-6701-409A-B380-A5D4A080C8EBQ35832931-BAE44BEF-8CC6-452A-AD29-856B66CE3A65Q36743340-47E0438C-BFBF-406F-A58F-A5B0282F649BQ36901944-359F30EF-7F40-44AC-A6CD-BB14016B7F5BQ37080697-35FEC7D6-63B8-4450-8B71-611BB9041207Q37199225-DD742994-7821-45C6-A0E1-B92F6F61A318Q39005891-88016A56-8DAE-47A1-B8EF-100FA2139BC8Q39236820-8C24BE0C-409F-4A74-A4AE-331FDA51DC80Q40078261-5AA8D2D3-58D0-4E85-B56E-D3B323F379A7
P2860
Long term survival in a patient with variant Creutzfeldt-Jakob disease treated with intraventricular pentosan polysulphate.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Long term survival in a patien ...... ricular pentosan polysulphate.
@en
Long term survival in a patien ...... ricular pentosan polysulphate.
@nl
type
label
Long term survival in a patien ...... ricular pentosan polysulphate.
@en
Long term survival in a patien ...... ricular pentosan polysulphate.
@nl
prefLabel
Long term survival in a patien ...... ricular pentosan polysulphate.
@en
Long term survival in a patien ...... ricular pentosan polysulphate.
@nl
P2093
P2860
P356
P1476
Long term survival in a patien ...... ricular pentosan polysulphate.
@en
P2093
P2860
P304
P356
10.1136/JNNP.2006.104505
P407
P577
2007-02-21T00:00:00Z